인도시아닌 그린 : 세계 시장 점유율과 순위, 천체 판매 및 수요 예측(2025-2031년)
Indocyanine Green - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1856180
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 인도시아닌 그린 시장 규모는 2024년에 8,330만 달러로 추정되며, 2031년에는 1억 2,100만 달러로 재조정되며, 예측 기간인 2025-2031년의 CAGR은 5.0%로 예측됩니다.
인도시아닌 그린(ICG)(CAS 3599-32-4)은 의료 진단에서 심박출량, 간기능, 간혈류량 측정 및 안과 혈관조영술에 사용되는 시안 색소입니다. 무균, 동결 건조된 녹색 분말로 800nm에 흡수 피크가 있습니다. 이 적외선 주파수는 망막층을 투과하므로 ICG 혈관조영술은 형광안저혈관조영술보다 더 깊은 순환 패턴을 영상화할 수 있습니다.
유럽이 가장 큰 인도시아닌 그린(CAS 3599-32-4) 시장으로 시장 점유율은 약 52%입니다. 주요 제조업체는 Pulsion Medical Systems AG, Dandong Yichuang Pharmaceutical, Diagnostic Green, SERB, Daiichi Sankyo, Santen Pharmaceutical, Aurolab, Eisai 등입니다. 상위 3개사가 약 60% 시장 점유율을 차지하고 있습니다.
시장 성장 촉진요인
정밀의료에 대한 수요 증가
종양 수술(다빈치 로봇 수술 등)에서 형광 네비게이션 기술의 보급으로 ICG는 수술 중 영상 진단의 중요한 시약이 되었습니다. 간암, 유방암 등 발병률이 높은 종양(중국에서는 매년 40만 명 이상의 간암 환자가 새로 발생하고 있다)이 수요를 주도하고 있습니다.
기술 향상과 적응력 확대
근적외선 이미징(NIR) 기술과 결합된 ICG는 림프관 조영술, 소화관 문합 등 새로운 분야로 확대되고 있습니다. 나노 캐리어 기술은 ICG의 안정성을 향상시키고, 이미징 시간을 연장한다(종양 표적 ICG 나노 제제 등).
최소침습수술의 보급
복강경, 흉강경 등 최소침습 수술의 비율이 증가하면서 ICG 이미징에 대한 수요가 급증하고 있습니다.
이 보고서는 세계의 인도시아닌 그린 시장에 대해 지역-국가별, 유형별, 용도별 분석과 함께 총 판매량, 판매 매출, 가격, 주요 기업 점유율, 시장 순위를 중심으로 종합적으로 조사 분석하여 전해드립니다.
인도시아닌 그린 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 판매량(K NOS) 및 판매매출(백만 달러)으로 제공합니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 구도를 평가하고, 현재 시장에서의 위치를 분석하고, 인도시아닌 그린에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.
목차
제1장 시장 개요
인도시아닌 그린 제품 소개
세계의 인도시아닌 그린 시장 규모 예측
인도시아닌 그린 시장 동향과 촉진요인
전제조건과 제약
조사 목적
검토 연수
제2장 기업별 경쟁 분석
세계의 인도시아닌 그린 기업 매출 순위(2024년)
세계의 인도시아닌 그린 기업별 매출(2020-2025년)
세계의 인도시아닌 그린 기업 판매 수량 순위(2024년)
세계의 인도시아닌 그린 기업별 판매 수량(2020-2025년)
세계의 인도시아닌 그린 기업별 평균 가격(2020-2025년)
주요 제조업체의 인도시아닌 그린 제조 기반 및 본사
주요 제조업체의 인도시아닌 그린 제품 제공
주요 제조업체의 인도시아닌 그린의 양산 개시 시기
인도시아닌 그린 시장의 경쟁 분석
M&A, 사업 확대
제3장 유형별 세분화
유형별 서론
25mg
50mg
세계의 인도시아닌 그린 유형별 판매액
세계의 인도시아닌 그린 유형별 판매 수량
세계의 인도시아닌 그린 유형별 평균 가격(2020-2031년)
제4장 용도별 세분화
용도별 서론
안과
신경외과
간 질환
기타
세계의 인도시아닌 그린의 용도별 판매액
세계의 인도시아닌 그린의 용도별 판매 수량
세계의 인도시아닌 그린의 용도별 평균 가격(2020-2031년)
제5장 지역별 세분화
세계의 인도시아닌 그린 지역별 판매액
세계의 인도시아닌 그린 지역별 판매 수량
세계의 인도시아닌 그린 지역별 평균 가격(2020-2031년)
북미
유럽
아시아태평양
남미
중동 및 아프리카
제6장 주요 국가/지역별 세분화
주요 국가·지역의 인도시아닌 그린의 판매액 성장 동향, 2020년 VS2024년 VS2031년
주요 국가·지역의 인도시아닌 그린의 판매액 및 판매 수량
미국
유럽
중국
일본
한국
동남아시아
인도
제7장 기업 개요
Pulsion Medical Systems AG
Dandong Yichuang Pharmaceutical
Daiichi Sankyo Company
SERB
Santen Pharmaceutical
Diagnostic Green
McKesson Corp
OriFarm
Jeil Pharmaceutical
Aurolab
Cellbion
Eisai
제8장 산업 체인 분석
제9장 조사 결과와 결론
제10장 부록
KSA
영문 목차
영문목차
The global market for Indocyanine Green was estimated to be worth US$ 83.3 million in 2024 and is forecast to a readjusted size of US$ 121 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Indocyanine green (ICG) (CAS 3599-32-4), a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.
Europe is the largest Indocyanine Green (CAS 3599-32-4) market with about 52% market share. USA is follower, accounting for about 22% market share.The key manufacturers are Pulsion Medical Systems AG,Dandong Yichuang Pharmaceutical, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical, Aurolab, Eisai, etc. Top 3 companies occupied about 60% market share.
Market drivers
Increasing demand for precision medicine
The popularization of fluorescence navigation technology in tumor surgery (such as da Vinci robotic surgery) has made ICG a key reagent for intraoperative imaging. High-incidence tumors such as liver cancer and breast cancer have driven demand (China has more than 400,000 new cases of liver cancer each year).
Technology upgrade and expansion of indications
ICG combined with near-infrared imaging (NIR) technology has been expanded to new scenarios such as lymphangiography and gastrointestinal anastomosis. Nanocarrier technology improves ICG stability and prolongs imaging time (such as tumor-targeted ICG nanoformulations).
Popularization of minimally invasive surgery
The proportion of minimally invasive surgeries such as laparoscopy and thoracoscopy has increased, and the demand for ICG imaging has surged.
This report aims to provide a comprehensive presentation of the global market for Indocyanine Green, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Indocyanine Green by region & country, by Type, and by Application.
The Indocyanine Green market size, estimations, and forecasts are provided in terms of sales volume (K NOS) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indocyanine Green.
Market Segmentation
By Company
Pulsion Medical Systems AG
Dandong Yichuang Pharmaceutical
Daiichi Sankyo Company
SERB
Santen Pharmaceutical
Diagnostic Green
McKesson Corp
OriFarm
Jeil Pharmaceutical
Aurolab
Cellbion
Eisai
Segment by Type
25mg
50mg
Segment by Application
Ophthalmology
Neurosurgery
Liver Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Indocyanine Green manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Indocyanine Green in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Indocyanine Green Product Introduction
1.2 Global Indocyanine Green Market Size Forecast
1.2.1 Global Indocyanine Green Sales Value (2020-2031)
1.2.2 Global Indocyanine Green Sales Volume (2020-2031)
1.2.3 Global Indocyanine Green Sales Price (2020-2031)
1.3 Indocyanine Green Market Trends & Drivers
1.3.1 Indocyanine Green Industry Trends
1.3.2 Indocyanine Green Market Drivers & Opportunity
1.3.3 Indocyanine Green Market Challenges
1.3.4 Indocyanine Green Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Indocyanine Green Players Revenue Ranking (2024)
2.2 Global Indocyanine Green Revenue by Company (2020-2025)
2.3 Global Indocyanine Green Players Sales Volume Ranking (2024)
2.4 Global Indocyanine Green Sales Volume by Company Players (2020-2025)
2.5 Global Indocyanine Green Average Price by Company (2020-2025)
2.6 Key Manufacturers Indocyanine Green Manufacturing Base and Headquarters
2.7 Key Manufacturers Indocyanine Green Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Indocyanine Green
2.9 Indocyanine Green Market Competitive Analysis
2.9.1 Indocyanine Green Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Indocyanine Green Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indocyanine Green as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 25mg
3.1.2 50mg
3.2 Global Indocyanine Green Sales Value by Type
3.2.1 Global Indocyanine Green Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Indocyanine Green Sales Value, by Type (2020-2031)
3.2.3 Global Indocyanine Green Sales Value, by Type (%) (2020-2031)
3.3 Global Indocyanine Green Sales Volume by Type
3.3.1 Global Indocyanine Green Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Indocyanine Green Sales Volume, by Type (2020-2031)
3.3.3 Global Indocyanine Green Sales Volume, by Type (%) (2020-2031)
3.4 Global Indocyanine Green Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ophthalmology
4.1.2 Neurosurgery
4.1.3 Liver Diseases
4.1.4 Others
4.2 Global Indocyanine Green Sales Value by Application
4.2.1 Global Indocyanine Green Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Indocyanine Green Sales Value, by Application (2020-2031)
4.2.3 Global Indocyanine Green Sales Value, by Application (%) (2020-2031)
4.3 Global Indocyanine Green Sales Volume by Application
4.3.1 Global Indocyanine Green Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Indocyanine Green Sales Volume, by Application (2020-2031)
4.3.3 Global Indocyanine Green Sales Volume, by Application (%) (2020-2031)
4.4 Global Indocyanine Green Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Indocyanine Green Sales Value by Region
5.1.1 Global Indocyanine Green Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Indocyanine Green Sales Value by Region (2020-2025)
5.1.3 Global Indocyanine Green Sales Value by Region (2026-2031)
5.1.4 Global Indocyanine Green Sales Value by Region (%), (2020-2031)
5.2 Global Indocyanine Green Sales Volume by Region
5.2.1 Global Indocyanine Green Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Indocyanine Green Sales Volume by Region (2020-2025)
5.2.3 Global Indocyanine Green Sales Volume by Region (2026-2031)
5.2.4 Global Indocyanine Green Sales Volume by Region (%), (2020-2031)
5.3 Global Indocyanine Green Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Indocyanine Green Sales Value, 2020-2031
5.4.2 North America Indocyanine Green Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Indocyanine Green Sales Value, 2020-2031
5.5.2 Europe Indocyanine Green Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Indocyanine Green Sales Value, 2020-2031
5.6.2 Asia Pacific Indocyanine Green Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Indocyanine Green Sales Value, 2020-2031
5.7.2 South America Indocyanine Green Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Indocyanine Green Sales Value, 2020-2031
5.8.2 Middle East & Africa Indocyanine Green Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Indocyanine Green Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Indocyanine Green Sales Value and Sales Volume
6.2.1 Key Countries/Regions Indocyanine Green Sales Value, 2020-2031
6.2.2 Key Countries/Regions Indocyanine Green Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Indocyanine Green Sales Value, 2020-2031
6.3.2 United States Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Indocyanine Green Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Indocyanine Green Sales Value, 2020-2031
6.4.2 Europe Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Indocyanine Green Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Indocyanine Green Sales Value, 2020-2031
6.5.2 China Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.5.3 China Indocyanine Green Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Indocyanine Green Sales Value, 2020-2031
6.6.2 Japan Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Indocyanine Green Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Indocyanine Green Sales Value, 2020-2031
6.7.2 South Korea Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Indocyanine Green Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Indocyanine Green Sales Value, 2020-2031
6.8.2 Southeast Asia Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Indocyanine Green Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Indocyanine Green Sales Value, 2020-2031
6.9.2 India Indocyanine Green Sales Value by Type (%), 2024 VS 2031
6.9.3 India Indocyanine Green Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Pulsion Medical Systems AG
7.1.1 Pulsion Medical Systems AG Company Information
7.1.2 Pulsion Medical Systems AG Introduction and Business Overview
7.1.3 Pulsion Medical Systems AG Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Pulsion Medical Systems AG Indocyanine Green Product Offerings
7.1.5 Pulsion Medical Systems AG Recent Development
7.2 Dandong Yichuang Pharmaceutical
7.2.1 Dandong Yichuang Pharmaceutical Company Information
7.2.2 Dandong Yichuang Pharmaceutical Introduction and Business Overview
7.2.3 Dandong Yichuang Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Dandong Yichuang Pharmaceutical Indocyanine Green Product Offerings
7.2.5 Dandong Yichuang Pharmaceutical Recent Development
7.3 Daiichi Sankyo Company
7.3.1 Daiichi Sankyo Company Company Information
7.3.2 Daiichi Sankyo Company Introduction and Business Overview
7.3.3 Daiichi Sankyo Company Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Daiichi Sankyo Company Indocyanine Green Product Offerings
7.3.5 Daiichi Sankyo Company Recent Development
7.4 SERB
7.4.1 SERB Company Information
7.4.2 SERB Introduction and Business Overview
7.4.3 SERB Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 SERB Indocyanine Green Product Offerings
7.4.5 SERB Recent Development
7.5 Santen Pharmaceutical
7.5.1 Santen Pharmaceutical Company Information
7.5.2 Santen Pharmaceutical Introduction and Business Overview
7.5.3 Santen Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Santen Pharmaceutical Indocyanine Green Product Offerings
7.5.5 Santen Pharmaceutical Recent Development
7.6 Diagnostic Green
7.6.1 Diagnostic Green Company Information
7.6.2 Diagnostic Green Introduction and Business Overview
7.6.3 Diagnostic Green Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Diagnostic Green Indocyanine Green Product Offerings
7.6.5 Diagnostic Green Recent Development
7.7 McKesson Corp
7.7.1 McKesson Corp Company Information
7.7.2 McKesson Corp Introduction and Business Overview
7.7.3 McKesson Corp Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 McKesson Corp Indocyanine Green Product Offerings
7.7.5 McKesson Corp Recent Development
7.8 OriFarm
7.8.1 OriFarm Company Information
7.8.2 OriFarm Introduction and Business Overview
7.8.3 OriFarm Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 OriFarm Indocyanine Green Product Offerings
7.8.5 OriFarm Recent Development
7.9 Jeil Pharmaceutical
7.9.1 Jeil Pharmaceutical Company Information
7.9.2 Jeil Pharmaceutical Introduction and Business Overview
7.9.3 Jeil Pharmaceutical Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Jeil Pharmaceutical Indocyanine Green Product Offerings
7.9.5 Jeil Pharmaceutical Recent Development
7.10 Aurolab
7.10.1 Aurolab Company Information
7.10.2 Aurolab Introduction and Business Overview
7.10.3 Aurolab Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Aurolab Indocyanine Green Product Offerings
7.10.5 Aurolab Recent Development
7.11 Cellbion
7.11.1 Cellbion Company Information
7.11.2 Cellbion Introduction and Business Overview
7.11.3 Cellbion Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Cellbion Indocyanine Green Product Offerings
7.11.5 Cellbion Recent Development
7.12 Eisai
7.12.1 Eisai Company Information
7.12.2 Eisai Introduction and Business Overview
7.12.3 Eisai Indocyanine Green Sales, Revenue, Price and Gross Margin (2020-2025)